SR-1277 structure
|
Common Name | SR-1277 | ||
---|---|---|---|---|
CAS Number | 1446715-47-4 | Molecular Weight | 477.50 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C21H19N9O3S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of SR-1277SR-1277 is a potent, selective and ATP competitive CK1δ/ε inhibitor, with IC50s of 49 nM and 260 nM, respectively. SR-1277 also inhibits FLT3, CDK4/cyclin D1, CDK6/cyclin D3 and CDK9/cyclin K, with IC50s of 305 nM, 1340 nM, 311 nM and 109 nM, respectively. SR-1277 can be used for the research of cancer[1]. |
Name | SR-1277 |
---|
Description | SR-1277 is a potent, selective and ATP competitive CK1δ/ε inhibitor, with IC50s of 49 nM and 260 nM, respectively. SR-1277 also inhibits FLT3, CDK4/cyclin D1, CDK6/cyclin D3 and CDK9/cyclin K, with IC50s of 305 nM, 1340 nM, 311 nM and 109 nM, respectively. SR-1277 can be used for the research of cancer[1]. |
---|---|
Related Catalog | |
Target |
CKIδ:49 nM (IC50) CKIϵ:260 nM (IC50) |
In Vitro | SR-1277 exhibits antiproliferative effects in A375 cells, with an EC50 of 22 nM[1]. |
In Vivo | SR-1277 (1 mg/kg; i.v.) exhibits Cmax (1.2 μM), Cl (2.8 ml/min/kg), AUC(1.26 μM•h), T1/2 (1.42 h) and brain penetration (24%) in mice[1]. |
References |
Molecular Formula | C21H19N9O3S |
---|---|
Molecular Weight | 477.50 |